Clin Osteol 2020; 25(4): 207-211

Vitamin D and bone qualityReview articles

Kužma Martin; Kršáková Eva; Kužmová Zuzana; Smaha Juraj; Jackuliak Peter; Killinger Zdenko; Payer Juraj
V. interná klinika LF UK a UNB, Nemocnica Ružinov, Bratislava

Introduction: The contribution of vitamin D to the reduction of fractures can be attributed, at least in part, to a beneficial effect on BMD, but also to an effect on bone microstructure. There is little evidence to explain the effect of vitamin D on bone microarchitecture.

Objective: To assess the relationship between 25(OH)D3 levels and quantitative / qualitative bone parameters in postmenopausal women.

Methods: A cross-sectional analysis of the effect of vitamin D levels on bone quality in postmenopausal women from endocrinology clinics undergoing DXA examination during 10/2015 to 03/2017, measured by BMD and TBS, was performed. Levels of 25 (OH) D3 were determined by chromatography using an HPLC system with UV detection (Chromsystem®; interassay variability CV: 0.8-3.0 %). A total of 129 patients were included in the final analysis. They were divided into two groups according to the serum concentration of vitamin D, the level of 30 ng/ml was considered as the cut-off value.

Results: The prevalence of vitamin D deficiency was more than 49,6 %. When comparing bone parameters between the two groups, we confirmed in the group with sufficient vitamin D levels a significantly higher number of patients (35 vs 55; p = 0.05) with prescribed vitamin D preparation and at the same time higher TBS values (1,241 vs 1,276; p = 0.05). BMD and bone turnover markers did not differ significantly. BMD in the total hip area was significantly lower in the group with sufficient vitamin D levels compared to the group with insufficient vitamin D levels.

Conclusion: Vitamin D affects bone metabolism and at the same time positively affects bone quality. Optimal vitamin D levels contribute to good bone structure.

Keywords: BMD; calcium; DXA; HR-pQCT; TBS; vitamin D

Received: October 8, 2020; Accepted: December 1, 2020; Published: December 11, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kužma M, Kršáková E, Kužmová Z, Smaha J, Jackuliak P, Killinger Z, Payer J. Vitamin D and bone quality. Clinical Osteology. 2020;25(4):207-211.
Download citation

References

  1. Khaw KT, Sneyd MJ, Compston J. Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women. BMJ 1992; 305(6848): 273-277. Dostupné z DOI: <http://dx.doi.org/10.1136/bmj.305.6848.273>. Go to original source...
  2. Bischoff-Ferrari HA, Dietrich T, Orav EJ et al. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004; 116(9): 634-639. Dostupné z DOI: <http://dx.doi.org/10.1016/j.amjmed.2003.12.029>. Go to original source...
  3. Adams JS, Kantorovich V, Wu C et al. Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density. J Clin Endocrinol Metab 1999; 84(8): 2729-2730. Dostupné z DOI: <http://dx.doi.org/10.1210/jcem.84.8.5899>. Go to original source...
  4. Ooms ME, Roos JC, Bezemer PD et al. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 1995; 80(4): 1052-1058. Dostupné z DOI: <http://dx.doi.org/10.1210/jcem.80.4.7714065>. Go to original source...
  5. Yao P, Bennett D, Mafham M et al. Vitamin D and Calcium for the Prevention of Fracture. JAMA Netw Open 2019; 2(12): e1917789. Dostupné z DOI: <http://dx.doi.org/10.1001/jamanetworkopen.2019.17789>. Go to original source...
  6. Laird E, Ward M, McSorley E et al. Vitamin D and bone health: potential mechanisms. Nutrients 2010; 2(7):693-724. Dostupné z DOI: <http://dx.doi.org/10.3390/nu2070693>. Go to original source...
  7. Payer J, Killinger Z (eds) et al. Osteoporóza. Herba: Bratislava 2012. ISBN 9788089171941.
  8. Bischoff-Ferrari HA, Willett WC, Wong JB et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293(18): 2257-2264. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.293.18.2257>. Go to original source...
  9. Bischoff-Ferrari HA, Willett WC, Wong JB et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169(6): 551-561. Dostupné z DOI: <http://dx.doi.org/10.1001/archinternmed.2008.600>. Go to original source...
  10. Shah I, Akhtar MK, Hisaindee S et al. Clinical diagnostic tools for vitamin D assessment. J Steroid Biochem Mol Biol 2018; 180 : 105-117. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jsbmb.2017.10.003>. Go to original source...
  11. Priemel M, von Domarus C, Klatte TO et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res 2010; 25(2): 305-312. Dostupné z DOI: <http://dx.doi.org/10.1359/jbmr.090728>. Go to original source...
  12. Alwan A, Al Rassy N, Berro A et al. Vitamin D and Trabecular Bone Score in a Group of Young Lebanese Adults. J Clin Densitom 2018; 21(3): 453-458. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jocd.2018.02.002>. Go to original source...
  13. Sundh D, Mellström D, Ljunggren Ö et al. Low serum vitamin D is associated with higher cortical porosity in elderly men. J Intern Med 2016; 280(5): 496-508. Dostupné z DOI: <http://dx.doi.org/10.1111/joim.12514>. Go to original source...
  14. Shiraishi A, Higashi S, Masaki T et al. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis. Calcif Tissue Int 2002; 71(1): 69-79. Dostupné z DOI: <http://dx.doi.org/10.1007/s00223-001-2090-y>. Go to original source...
  15. Bislev LS, Langagergaard Rodbro L, Rolighed L et al. Effects of Vitamin D3 Supplementation on Muscle Strength, Mass, and Physical Performance in Women with Vitamin D Insufficiency: A Randomized Placebo-Controlled Trial. Calcif Tissue Int 2018; 103(5): 483-493. Dostupné z DOI: <http://dx.doi.org/10.1007/s00223-018-0443-z>. Go to original source...




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.